Illumina, Inc.

ILMN · NASDAQ · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Ro Khanna D · HOUSE · CA	−$517K – $645K −$671K – $675K today 74 filings · last Jan 29, 2026
Susan A. Davis D · HOUSE · CA	$15K – $50K $13K – $44K today 1 filing · last Jan 11, 2019
Thomas H. Kean, Jr. R · HOUSE · NJ	$3K – $45K $9K – $138K today 3 filings · last Apr 1, 2025
K. Michael Conaway R · HOUSE · TX	$1K – $15K $1K – $21K today 1 filing · last Feb 9, 2015
Gilbert Ray Cisneros, Jr. D · HOUSE · CA	$1K – $15K $2K – $34K today 1 filing · last Feb 10, 2026
Sheldon Whitehouse D · SENATE · RI	−$14K – $14K −$16K – $12K today 2 filings · last Mar 11, 2020
Lisa C. McClain R · HOUSE · MI	−$28K – $28K −$68K – $83K today 4 filings · last Oct 31, 2025
Josh Gottheimer D · HOUSE · NJ	−$44K – $12K −$49K – $11K today 4 filings · last Nov 6, 2020
Kathy E. Manning D · HOUSE · NC	−$62K – $29K −$73K – $9K today 5 filings · last Jun 10, 2022
Donald S. Beyer, Jr. D · HOUSE · VA	−$132K – $99K −$102K – $85K today 15 filings · last Feb 28, 2022

Recent transactions

Trades from May 23, 2022 – Feb 10, 2026

Politician	Type	Filed after	Amount
Gilbert Ray Cisneros, Jr. D · HOUSE · CA-31	Buy	27 days Feb 10, 2026 → Mar 9, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	8 days Jan 29, 2026 → Feb 6, 2026	≥$1K
Lisa C. McClain R · HOUSE · MI-9	Sell	21 days Oct 31, 2025 → Nov 21, 2025	≥$1K
Lisa C. McClain R · HOUSE · MI-9	Sell	22 days Oct 30, 2025 → Nov 21, 2025	≥$1K
Lisa C. McClain R · HOUSE · MI-9	Buy	22 days Oct 30, 2025 → Nov 21, 2025	≥$1K
Lisa C. McClain R · HOUSE · MI-9	Buy	65 days Jun 9, 2025 → Aug 13, 2025	≥$1K
Thomas H. Kean, Jr. R · HOUSE · NJ-7	Buy	44 days Apr 1, 2025 → May 15, 2025	≥$1K
Thomas H. Kean, Jr. R · HOUSE · NJ-7	Buy	17 days Apr 1, 2025 → Apr 18, 2025	≥$1K
Ro Khanna D · HOUSE · CA-17	Sell	9 days Feb 25, 2025 → Mar 6, 2025	≥$1K
Michael C. Burgess R · HOUSE · TX-26	Sell	32 days Aug 30, 2024 → Oct 1, 2024	≥$15K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

971

13F shares

157.1M

Total invested

$27.6B

Ownership

102.7%

New positions

163

Closed positions

Increased positions

465

Reduced positions

337

Put/Call ratio

0.34

Holder	Reported	Shares	Value	Δ Qtr
BLACKROCK, INC.	8/7/2026	19.2M	$3.4B	+0.88%
CAPITAL WORLD INVESTORS	8/12/2026	15.4M	$2.7B	−0.80%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	6.6M	$1.2B	−2.88%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	6.6M	$1.2B	−0.11%
STATE STREET CORP	9/22/2026	6.5M	$1.1B	+1.21%
WCM INVESTMENT MANAGEMENT, LLC	8/13/2026	6.2M	$1.1B	+4.79%
FMR LLC	8/13/2026	4.5M	$795.4M	+192.43%
AQR CAPITAL MANAGEMENT LLC	8/14/2026	3.5M	$623.2M	−10.97%
PRIMECAP MANAGEMENT CO/CA/	8/14/2026	3.5M	$618.0M	+70.01%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	2.9M	$516.7M	−3.43%
CORVEX MANAGEMENT LP	8/14/2026	2.8M	$497.7M	−26.09%
JUPITER TOPCO LLC	8/14/2026	2M	$358.7M	—
INVESCO LTD.	8/14/2026	2M	$350.6M	−24.96%
LOOMIS SAYLES & CO L P	8/14/2026	1.9M	$339.7M	−34.35%
WELLINGTON MANAGEMENT GROUP LLP	8/14/2026	1.8M	$318.8M	+190.10%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	8/3/2026	1.7M	$308.5M	+70.38%
BANK OF NEW YORK MELLON CORP	8/6/2026	1.7M	$293.8M	+11.41%
MORGAN STANLEY	8/13/2026	1.7M	$290.9M	−10.25%
UBS ASSET MANAGEMENT AMERICAS INC	8/13/2026	1.5M	$264.1M	−3.91%
BANK OF AMERICA CORP /DE/	8/14/2026	1.5M	$255.9M	−4.04%
NORTHERN TRUST CORP	8/13/2026	1.4M	$251.3M	−9.44%
AGF MANAGEMENT LTD	8/10/2026	1.4M	$240.0M	—
BAILLIE GIFFORD & CO	8/6/2026	1.3M	$234.9M	−12.98%
JPMORGAN CHASE & CO	8/12/2026	1.2M	$213.9M	+14.53%
LEGAL & GENERAL GROUP PLC	8/14/2026	1.2M	$206.3M	+2.05%

Insider transactions

Insider	Type	Transacted	Price	Date
Thaysen Jacob	F-INKIND	1.3K	$293.69	Oct 5

Analyst consensus

Buy50 analysts

Bearish · 6 · Hold · 17 · Bullish · 27

Earnings history

	EPS	Estimate
Q3 2024	$1.14	$0.88	Beat
Q4 2024	$0.86	$0.92	Miss
Q1 2025	$0.97	$0.94	Beat
Q2 2025	$1.19	$1.02	Beat
Q3 2025	$1.34	$1.17	Beat
Q4 2025	$1.35	$1.24	Beat
Q1 2026	$1.15	$1.05	Beat
Q2 2026	$1.31	$1.23	Beat

Peers

Company overview

IPO dateJul 28, 2000

CEOJacob Thaysen

Employees8,600

SectorHealthcare

IndustryMedical - Diagnostics & Research

CountryUS

ExchangeNASDAQ Global Select

Websitewww.illumina.com

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.